Prescription ID
Products
Action
REVOLAX uses non-animal-based hyaluronic acid of high purity. It is a naturally derived substance, optimised to synchronise with human skin tissue.
REVOLAX has a unique cross-linking technology that does not need free hyaluronic acid to adjust the physical properties of its gel formula.
One of REVOLAX’s defining properties is its malleable consistency. This creates both immediate and long lasting volume, allowing the product to break down evenly with a natural finish.
REVOLAX consists of a regular and dense monophasic structure, which makes the gel product stable and consistent. The consistency of the pattern allows for naturally harmonised volume and smooth injection, promoting a stronger support system within the skin structure.
REVOLAX has a low percentage of product migration, meaning that once injected, the product is more likely to stay closer to the injection site with improved accuracy.
u003cspan style=u0022font-weight: 400;u0022u003eAt REVOLAX, we are committed to delivering safe, low-risk premium-technology dermal fillers that can compete with industry giants in terms of ease of use, quality results, and longevity.u003c/spanu003ernrnu003cspan style=u0022font-weight: 400;u0022u003eSo, what is REVOLAX and how does it differ from current u003c/spanu003eu003cstrongu003eu003ca href=u0022https://foxpharma.co.uk/product-category/dermal-fillers/u0022u003edermal fillersu003c/au003eu003c/strongu003eu003cspan style=u0022font-weight: 400;u0022u003e on the market? Since its launch in 2012, REVOLAX has grown exponentially to become one of the leading dermal fillers in South Korea. With pioneering cross-linking technology and unique consistency and stability, it is easy to see how the product has made such an impact within the Asian market.u003c/spanu003ernrnu003cspan style=u0022font-weight: 400;u0022u003eAs worldwide leaders within the cosmetic industry, you can expect the same South Korean high-quality standards in every aspect of the manufacturing process and product, reinforced by ISO1509001 + ISO15013485:2012 quality standards and independent scientific trial data.u003c/spanu003ernrnu003cspan style=u0022font-weight: 400;u0022u003eREVOLAX has a stringent quality check process that completely removes all traces of the crosslinking agent BDDE from the finished product, through its rigorous dialysis process. REVOLAX is continuously innovating to ensure continued development and progression within the product line. u003c/spanu003eu003cstrongu003eu003ca href=u0022https://foxpharma.co.uk/shopu0022u003eBuy REVOLAXu003c/au003eu003c/strongu003eu003cspan style=u0022font-weight: 400;u0022u003e today and help your patients achieve their ideal look in a safe, qualitative, and lasting way.u003c/spanu003e